Stocks and Investing
Stocks and Investing
Wed, July 10, 2024
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
[ Wed, Jul 10th 2024
] - WOPRAI
Joanne Wuensch Maintained (ZBH) at Hold with Decreased Target to $120 on, Jul 10th, 2024
Joanne Wuensch of Citigroup, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Hold with Decreased Target from $134 to $120 on, Jul 10th, 2024.
Joanne has made no other calls on ZBH in the last 4 months.
There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 5 agree with Joanne's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vijay Kumar of "Evercore ISI Group" Maintained at Hold with Decreased Target to $115 on, Tuesday, July 2nd, 2024
- Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $115 on, Monday, July 1st, 2024
- David Roman of "Goldman Sachs" Initiated at Hold and Held Target at $129 on, Thursday, May 30th, 2024
- Mike Matson of "Needham" Reiterated at Hold on, Thursday, May 30th, 2024
- Richard Newitter of "Truist Securities" Maintained at Hold with Decreased Target to $130 on, Friday, May 3rd, 2024
These are the ratings of the 3 analyists that currently disagree with Joanne
- Matt Miksic of "Barclays" Maintained at Sell with Decreased Target to $125 on, Friday, May 31st, 2024
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $150 on, Tuesday, May 21st, 2024
- Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $155 on, Friday, May 3rd, 2024
Contributing Sources